I am very interested in EIQ, however, it looks like ultromics ( developed with oxford uni) has first in class advantage. Already has FDA approval. I am aware ultromics is initially interested mainly in heart failure, but only a matter of time to move onto AS. Does EIQ have any sig advantage over Ultromics?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $153.2M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 23.5¢ | $68.91K | 290.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 223387 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 51645 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |